Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467467 · ClinicalTrials.gov registry record · Phase 3
Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort
A Phase 3 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT00467467: Completed Phase 3 study, sponsored by University of Minnesota.
NCT00467467 is a Phase 3 study that has completed, run by University of Minnesota. The registered enrollment target is 60 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00467467, a Phase 3 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
To assess the impact of alfuzosin vs. placebo on ureteral stent discomfort, urinary symptoms and quality of life.
Interventions
- DRUG Alfuzosin Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
What the finished NCT00467467 record still lists
NCT00467467 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Alfuzosin Hydrochloride is the first listed.
NCT00467467 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00467467 about?
NCT00467467 is a clinical study titled "Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort". To assess the impact of alfuzosin vs. placebo on ureteral stent discomfort, urinary symptoms and quality of life.
What is the current status of trial NCT00467467?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2006-06. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00467467?
The interventions under investigation include: Alfuzosin Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00467467?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00467467's enrollment target sits among peer trials
60 1804th of 2000 higher than 177 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia